Even though dupilumab was a late entrant to the market to treat asthma, its efficacy “speaks for itself." 

Dr Neal Jain Explains How Dupilumab Differentiated Itself as a Late Entrant to the Asthma Market

Defining the economic burden and the pathophysiology of type 2 inflammation in asthma.

Economic Burden and Type 2 Inflammation in Asthma

Findings from a new study do not support the use of vitamin D supplementation to prevent severe asthma exacerbations in children with persistent asthma.

Vitamin D No Better Than Placebo at Preventing Severe Asthma Attacks

Patients who have oral corticosteroid–dependent asthma are recommended to use dupilumab, which reduces the use of oral steroids.

Dr Neal Jain Discusses the Use of Dupilumab in Oral Steroid–Dependent Asthma

Compendium

Videos

In the real world, dupilumab has been as effective as the results in clinical trials, and patients are seeing low exacerbation rates, emergency department visits, and hospitalizations, explained Neal Jain, MD, FAAP, FAAAAI.

Dr Neal Jain on the Real-World Results of Dupilumab in Asthma

Articles

Following the onset of the coronavirus disease 2019 (COVID-19) pandemic, changes in pediatric asthma health care delivery patterns resulted in reduced hospital admissions and systemic steroid prescriptions in Philadelphia.

Pediatric Asthma Health Care Utilization Following Onset of COVID-19 Pandemic

The 2-year study will investigate how devices like the Apple Watch and the iPhone can help patients with asthma better manage their condition.

Anthem, Apple to Study How to Improve Asthma Self-management With Everyday Devices

Patients who have oral corticosteroid–dependent asthma are recommended to use dupilumab, which reduces the use of oral steroids, explained Neal Jain, MD, FAAP, FAAAAI, of Arizona Allergy & Immunology Research.

The high rate of persistence found in the real-world study indicates dupilumab was well tolerated and patients were satisfied with its effectiveness.

Real-World Study Finds High Persistence With Dupilumab in Atopic Dermatitis

The broadest real-life study of dupilumab in atopic dermatitis (AD) found significant improvements in adults with moderate to severe AD that were even greater than the results reported in clinical trials.

Real-World Study: Dupilumab for Atopic Dermatitis More Effective Than Clinical Trial Results

Even though dupilumab was a late entrant to the market to treat asthma, its efficacy “speaks for itself,” said Neal Jain MD, FAAP, FAAAAI, of Arizona Allergy & Immunology Research, Arcadia Allergy & Asthma, and San Tan Allergy & Asthma.

Findings from a new study in JAMA do not support the use of vitamin D3 supplementation to prevent severe asthma exacerbations in children with persistent asthma.

Inflammatory skin diseases are often diagnosed by "first impression" and can be easily misdiagnosed. A new smartphone app using artificial intelligence (AI) may be able to assist with the diagnosis of psoriasis, atopic dermatitis, and eczema.

AI Smartphone App Could Improve Diagnosis of Psoriasis, Atopic Dermatitis, Eczema

Acute stress was found to be a possible trigger following the loss of a partner, but not a factor in long-term risk for either disorder.

Inflammation

Dr Neal Jain Explains How Dupilumab Differentiated Itself as a Late Entrant to the Asthma Market

Economic Burden and Type 2 Inflammation in Asthma

Vitamin D No Better Than Placebo at Preventing Severe Asthma Attacks

Dr Neal Jain Discusses the Use of Dupilumab in Oral Steroid–Dependent Asthma

New content coming soon, please check back later.